Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II intra-arterial melphalan for advanced intraocular unilateral retinoblastoma
2009-010737-47Phase 2Active
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melphalan in retinoblastoma (Rb), sponsored by Sant Joan de Déu Hospital. Primary endpoints: Objective response to treatment and Volumetric tumor size change. Started Apr 2009; status: active.
02
Drugs
melphalan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on 2009-010737-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010737-47.